NOD2 to the IKK signaling complex [11] , it has been for NF-kB activation [18] [19] [20] . To determine the effect of RIP2's kinase activity on NEMO ubiquitinylation, we proposed that RIP2 serves as a key mediator to determine whether NOD2 functions in a positive or negative transfected a kinase-dead version (K47A RIP2) of RIP2 into cells in the presence of K399R NEMO and HAmanner in NF-kB signaling [16] . However, the complexity of this signaling pathway suggests that in addition to ubiquitin. Both RIP2 and K47A RIP2 induced the ubiquitinylation of NEMO ( Figure 1B ). This finding is consistent acting as a nucleating factor, RIP2 may have other functions. The ability of RIP2 to nucleate the IKK signalowith previous findings showing that RIP2 functions as a scaffolding protein to activate NF-kB; RIP2's kinase some does not account for the complexity of signaling initiated by NOD2 [10] .
activity is dispensable for NF-kB activation [18] [19] [20] . Ubiquitin conjugation has been most prominently asIn this work, we have studied the effect of NOD2 and RIP2 on the IKK signaling complex. We show that both sociated with protein degradation, but it is becoming increasingly recognized that ubiquitinylation plays a key RIP2 and NOD2 strongly induce the ubiquitinylation of NEMO, a key component of the IKK signaling complex.
role in cell signaling (reviewed in [24] ). To determine if RIP2-induced NEMO ubiquitinylation causes NEMO This ubiquitinylation occurs in an agonist-dependent manner, and Crohn's disease-associated polymordegradation via the proteosome, we transfected cells with either wild-type NEMO or K399R NEMO in the presphisms of NOD2 lose the ability to ubiquitinylate NEMO. siRNA experiments show that RIP2 is required for NOD2-ence or absence of RIP2. 24 hr after transfection, cells were exposed to the proteosome inhibitor MG132 or to induced NEMO ubiquitinylation, and the Crohn's disease-associated NOD2 polymorphisms that cannot vehicle control. Lysates were made, and Western blots were performed. A ␤-catenin blot served as a positive ubuiquitinylate NEMO show a decreased ability to bind RIP2. We map the ubiquitinylation site of NEMO to a control for MG132's inhibition of the proteosome ( Figure  2A ) and showed that the hyperphosphorylated, nondenovel site (lysine 285) and show by mass spectrometry that this ubiquitinylation occurs in vivo. Lastly, we show graded form of ␤-catenin was present in the presence of MG132 (Figure 2A ). NEMO expression was essentially that the K63 deubiquitinylating enzyme CYLD can reverse RIP2-mediated NEMO ubiquitinylation and that unchanged in the presence or absence of MG132, indicating that NEMO ubiquitinylation likely did not lead to CYLD can strongly inhibit RIP2-induced NF-kB activation. Collectively, these data suggest that this novel proteosomal degradation (Figure 2A ). Because of this experiment, we considered the possibility that NEMO mode of regulation of the NF-kB signaling pathway could be one factor underlying the pathogenesis of Crohn's was ubiquitinylated to influence signaling pathways rather than proteosomal degradation. disease.
Ubiquitin contains seven lysines that can be covalently linked in polyubiquitin chains, and which lysine is Results and Discussion linked often determines function [24] . For instance, K48-linked chains typically lead to proteosomal degredation RIP2 Induces K63-Linked Ubiquitinylation of the linked protein [24] . To determine which ubiquitin of NEMO at a Novel Site of Attachment chain was formed on NEMO, we utilized a mutant version In the course of studying RIP2's effect on NF-kB and of ubiquitin in which all of the lysines were mutated to coexpressing both RIP2 and NEMO, we found that RIP2 non-ubiquitin-chain-forming arginine with the exception induced a large (Ͼ8 kDa) mobility shift in NEMO (Figure of a single target lysine. In all, K6-, K11-, K29-, K48-, and S1). Given the size of the shift, we hypothesized that K63-only ubiquitin mutants were used in the experiment this shift was due to NEMO ubiquitinylation. Figure 3, lane 4) . The NOD2 agonist, MDP, has limited known, and kinase activity appears to be dispensable the complexity of the search for the ubiquitinylation site, we initially used a genetic approach. RIP2 is conserved in zebrafish, but not in Drosophila. We identified the zebrafish NEMO and compared its sequence to human NEMO. Only four lysines are conserved (K115, K224, K285, and the previously mutated K399) ( Figure 6A) . K115, K224, and K285 were mutated in a K399R background and expressed in the presence of HA-tagged ubiquitin. RIP2 caused the induction of NEMO ubiquitinylation in the K115R K399R mutant and the K224R K399R mutant but caused decreased ubiquitinylation of the K285R K399R mutant ( Figure 6B ). These data imply that K285 is a major site of RIP2-induced ubiquitinylation; however, the lack of NEMO ubiquitinylation was not complete, suggesting that additional ubiquitinylation sites are present. To verify that K285 is ubiquitinylated in vivo, we coexpressed K399R NEMO and RIP2 and immunoprecipitated NEMO. The majority of the NEMO purified was present at the expected 50-52 kDa size. We also detected several lower-mobility proteins, including a sharp band with an apparent size of 68 kDa ( Figure 6C ). This sharp 68 kDa band was excised and subjected to mass spectrometry. Ubiquitin-modified lysine does not cleave with trypsin and shows a characteristic gycine-glycine signature upon tryptic cleavage [28]. By mass spectrometry analysis, the 68 kDa band consisted only of NEMO containing the characteristic ubiquitin signature at lysine 285 ( Figure 6D ). Given the fact that the K285R K399R mutant NEMO abolished a large proportion of ubiquinylated NEMO (Figure 2B ), we believe that the K285 site is the major site of RIP2-induced NEMO ubiquitinylation. shown to downregulate TLR2 signaling, a precedent for and induce NEMO ubiquitinylation at a novel site of cross-talk between these signaling pathways now exists attachment. This ubiquitinylation is essential for RIP2's
RIP2-Induced NEMO Ubiquitinylation Activates NF-kB Signaling, and this Activation Can
[15]. RIP2 appears to be a central mediator in this potenactivation of the NF-kB signaling pathway. The downtial inflammatory cross-talk because it can bind to both stream effectors for this process could involve either TLR2 [17] and NOD2 [11] and is required for signaling the activation of a K63 E3 ubiquitin ligase or the inhibition in both of these signaling pathways [17] . Given that RIP2 of a K63 deubiquitinase (model in Figure 7 To ensure that the L1007insC mutant was behaving similarly to This locally high concentration encourages the formation of RIP2 published reports, we performed NF-kB reporter assays, whose oligomers, which then activate either a K63 ubiquitin ligase or a K63 results were similar to those of published reports (data not shown). deubiquitinating enzyme.
Primer sequences used to generate clones and mutants are available upon request. siRNA directed against RIP2 as well as the control sirna oligo was obtained from Ambion. MDP was obtained from NEMO, we believe that this RIP2-induced ubiquitinylation Bachem. of NEMO is a good candidate for mediating the cross-talk between these inflammatory signaling pathways.
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